The Female Health Company to Host Third Quarter Conference Call on Friday, August
5, 2011
CHICAGO, July 29, 2011 /PRNewswire via COMTEX/ -- The Female Health Company
(FHCO) today announced that it will host an investor conference call to discuss
its operating results for the third quarter and first nine months of FY2011 on
Friday, August 5, 2011 at 11:00 a.m. Eastern Time (EDT). The Company expects to
report its operating results earlier the same day.
Shareholders and other interested parties may participate in the conference call
by dialing 1-877-374-8416 (international participants dial 1-412-317-6716) and
asking to be connected to "The Female Health Company Conference Call" a few
minutes before 11:00 a.m. EDT on August 5, 2011. A replay of the call will be
available one hour after the call through 9:00 a.m. EDT on Monday, August 22,
2011 by dialing 877-344-7529 (international callers dial 412-317-0088) and
entering the conference ID 10002775.
About The Female Health Company
The Female Health Company, based in Chicago, Illinois, manufactures and markets
the FC2 Female Condom? (FC2), which is available in the U.S. and about 120 other
countries globally. The Company owns certain worldwide rights to the FC2 Female
Condom?, including patents that have been issued in the U.S., Europe, Canada,
Australia, South Africa, Japan, Spain, Greece, Turkey and the People's Republic
of China, and pending in various countries. The FC2 Female Condom? is the only
available FDA-approved product controlled by a woman that offers dual protection
against sexually transmitted diseases, including HIV/AIDS, and unintended
pregnancy. The World Health Organization (WHO) has cleared FC2 for purchase by
U.N. agencies. |
